CN Patent

CN114222578B — 钙敏感受体激动剂化合物及其应用

Assigned to Shanghai Hengrui Pharmaceutical Co Ltd · Expires 2024-06-25 · 2y expired

What this patent protects

提供钙敏感受体激动剂化合物及其应用。具体而言，提供一系列多肽钙敏感受体激动剂化合物及其可药用盐的药物组合物，其对人类钙敏感受体(Calcium‑sensing Receptor,CaSR)具有激动剂作用进而降低血浆甲状旁腺激素和血清钙离子水平，并可以用于原发性甲状旁腺功能亢进，继发性甲状旁腺功能亢进，肿瘤引发的高钙血症等代谢类疾病的治疗。

USPTO Abstract

提供钙敏感受体激动剂化合物及其应用。具体而言，提供一系列多肽钙敏感受体激动剂化合物及其可药用盐的药物组合物，其对人类钙敏感受体(Calcium‑sensing Receptor,CaSR)具有激动剂作用进而降低血浆甲状旁腺激素和血清钙离子水平，并可以用于原发性甲状旁腺功能亢进，继发性甲状旁腺功能亢进，肿瘤引发的高钙血症等代谢类疾病的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN114222578B
Jurisdiction
CN
Classification
—
Expires
2024-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hengrui Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.